RxDoctor Payments Data

Stephen Beaudoin, MD

Internal Medicine · Newburyport, MANPI 1902808124

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 35th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$672,969
Medicare patients
1,567
Services billed
29,298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban61$53,418
OxycontinOxycodone Hcl34$48,285
OzempicSemaglutide30$38,714
JardianceEmpagliflozin27$29,378
TrulicityDulaglutide18$22,792
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$14,417
Xtampza ErOxycodone Myristate14$7,925
Arnuity ElliptaFluticasone Furoate23$7,832
Rosuvastatin Calcium117$3,414
Oxycodone Hcl112$3,065
Atorvastatin Calcium215$2,515
Wixela InhubFluticasone Propion/Salmeterol11$2,339
Duloxetine Hcl38$1,918
Albuterol Sulfate HfaAlbuterol Sulfate37$1,361
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine52$1,339

Paid to pharmacies, not to this prescriber.

Other internal medicine in Newburyport

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →